Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Ventures
  • Consumer Unit
  • Publications
  • Media
  • Contact

Pain

Product Candidate

ArtiMinex

Björklund Pharma AS introduces ArtiMinex, a groundbreaking solution designed to address Achilles tendon and heel pain (ATHP), a prevalent concern among athletes, military personnel, and individuals engaged in physically demanding occupations. This discomfort often stems from improper biomechanics and overuse of the lower extremities.

ArtiMinex employs mineral displacement therapy, a pioneering approach to restore the optimal mineral balance within the osteoarticular districts. This innovative therapy can alleviate heel pain and improve joint health by rectifying mineral imbalances.

A collaborative effort with international researchers culminated in the publication of a clinical pilot study in Science & Healthcare (October 2021), further validating the efficacy of ArtiMinex in addressing ATHP (1).

Reference

1. Dhillon KS, Singh J, Chirumbolo S, Chartrand MS, Lyall JS, Bjørklund G. Treatment of Heel Pain with Mineral Salts Exchange: Protocol for a Clinical Pilot Study. Science & Healthcare 2021; 23(5): 118-124.

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS